|
Non-alcoholic fatty pancreas disease is an emerging condition and an important risk factor for pancreatic cancer, and obesity promotes pancreatic inflammation and disease progression. Lactoferrin is an iron-binding, immunomodulatory glycoprotein found in milk that has been reported to improve hepatic insulin resistance and pancreatic dysfunction in high-fat diet and streptozotocin-induced diabetic mice. However, the effect of lactoferrin-fortified stirred yogurt on obesity-associated pancreatic damage had not been studied. Using a high-fat diet rat model, 48 female albino rats were divided into six groups and treated orally for 45 days: negative control, positive control (1% cholesterol), stirred yogurt (SY), lactoferrin (LF, 100 mg/kg bw), and lactoferrin-fortified stirred yogurt at two doses (SY-LF1, 50 mg/kg bw; SY-LF2, 100 mg/kg bw). Lactoferrin recovery after fermentation exceeded 98%, and lactoferrin increased viable Lactobacillus acidophilus counts. The high-fat diet group showed significant increases in weight gain (44.72%), total cholesterol (151.33 mg/dL), triglycerides (142.67 mg/dL), LDL (85.37 mg/dL), glucose (141.33 mg/dL), amylase (39.33 U/mL), and lipase (23.43 U/mL), a significant decrease in HDL (37.33 mg/dL), and pancreatic congestion, acinar cell degeneration, and vacuolation. Lactoferrin-fortified yogurt significantly improved these indicators, with SY-LF2 being most effective (weight gain 24.19%, glucose 80.00 mg/dL, amylase 26.90 U/mL, lipase 10.27 U/mL) and pancreatic tissue returning to a near-normal structure. Overall, lactoferrin-supplemented stirred yogurt protected against high-fat diet-induced pancreatic damage and shows promise for functional fermented dairy product development.
- Du, Y., D. Li, J. Chen, Y.-H. Li, Z. Zhang, K. Hidayat, Z. Wan, J.-Y. Xu, and L.-Q. Qin. 2022. Lactoferrin improves hepatic insulin resistance and pancreatic dysfunction in high-fat diet and streptozotocin-induced diabetic mice. Nutr. Res. 103:47–58.
- Hassan, M. A., T. G. Abedelmaksoud, and A. A. Abd El-Maksoud. 2022. Effects of lactoferrin supplemented with fermented milk on obesity-associated pancreatic damage in rats. Life 12:2019.
|
|